H.R. 1725 · 114th Congress
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Passed the House without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 114th Congress ended.
R
WhitfieldSponsor13 cosponsors · 8 D, 5 R
R
Bucshon
JK
D
Kennedy
FP
D
Pallone
MB
R
Burgess
KC
D
Clark
JM
D
McGovern
GB
R
Bilirakis
BJ
R
Johnson
DM
D
Matsui
WK
D
Keating
SM
D
Moulton
BC
R
Comstock
AK
D
Kuster3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced Mar 26, 2015
- House Passed Sep 8, 2015
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
What it does: CRS summary · Passed House amended · Sep 8, 2015
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
(Sec. 2) Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities.
(Sec. 3) Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to:
- allow grants to be used to maintain and operate existing state controlled substance monitoring programs,
- require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees,
- require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and
- expand the program to include any commonwealth or territory of the United States.
Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes to make that information available to other entities for research purposes.
Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
Latest action (Sep 9, 2015): Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: House · Introduced: Mar 26, 2015
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- House Introduced Mar 26, 2015
- House Passed Sep 8, 2015
No recorded floor vote found.